date,title,source
Nov-01-18,Urovant Sciences Announces Publication of Phase 2b Data for Vibegron in European Urology,Business Wire
Nov-05-18,Urovant Sciences to Report 2018 Second Fiscal Quarter Financial Results,Business Wire
Nov-08-18,Urovant Sciences Completes Patient Enrollment in Phase 3 Pivotal Trial Studying Vibegron for Overactive Bladder,Business Wire
Nov-12-18,"Urovant Sciences Reports Financial Results for the Second Fiscal Quarter Ended September 30, 2018 and Provides Corporate Update",Business Wire
Nov-19-18,Urovant Sciences Announces Participation in Piper Jaffray Healthcare Conference,Business Wire
